Breaking News: Marpai Secures Up to $5 Million in Non-Dilutive Growth Funding from JGB!

Marpai, Inc. Secures Additional $5,000,000 Funding for Growth Initiatives TAMPA, Fla., Jan. 6, 2025 /PRNewswire/ — Marpai, Inc. (“Marpai” or the “Company”) (OTCQX: MRAI), a technology platform company, which operates as a national Third-Party Administrator (TPA) through its subsidiaries and is transforming the $22 billion TPA market by offering affordable, intelligent, healthcare solutions to self-funded…

Read More

Is Invesco Mortgage Capital Too Risky to Consider? Exploring the Potential Risks and Rewards

Welcome to our blog post about Invesco Mortgage Capital Inc. About Invesco Mortgage Capital Inc. Invesco Mortgage Capital Inc. is a Real Estate Investment Trust (REIT) that specializes in mortgage-backed securities and related assets. These assets include residential and commercial mortgage-backed securities, U.S. Treasury securities, and real estate financing arrangements. The company’s investment thesis focuses…

Read More

Smart Eye AB Publ Licenses Iris Recognition Technology from Fingerprint Cards AB Publ for 50 MSEK: A Strategic Partnership for Enhanced Security and User Experience in Automotive and Enterprise

Smart Eye Enters Agreement to License Iris Recognition Technology In a move that highlights their commitment to cutting-edge technology and innovation, Smart Eye has announced a new agreement to license iris recognition technology from Swedish company Fingerprint Cards. The total consideration for this agreement is set at SEK 50 million plus VAT, showcasing the significant…

Read More

Applied Therapeutics Inc. Faces Securities Law Violations Lawsuit: What Impacted Investors Need to Know

The Schall Law Firm Reminds Investors of Class Action Lawsuit Against Applied Therapeutics, Inc. Investors’ Rights Alert Los Angeles, CA / Accesswire / January 6, 2025 The Schall Law Firm, a national shareholder rights litigation firm, recently reminded investors of a class action lawsuit against Applied Therapeutics, Inc. This lawsuit alleges violations of 10(b) and…

Read More

Attention Shareholders: Take Action Now – Class Action Lawsuit Filed Against Revance Therapeutics Inc. (RVNC) by Holzer & Holzer, LLC – Contact Us for Support

Shareholder Class Action Lawsuit Filed Against Revance Therapeutics, Inc. ATLANTA, Jan. 06, 2025 (GLOBE NEWSWIRE) A shareholder class action lawsuit has been filed against Revance Therapeutics, Inc. (“Revance” or the “Company”) (NASDAQ: RVNC). The lawsuit alleges that Defendants made materially false and/or misleading statements, and/or failed to disclose material adverse facts about Revance’s business, operations,…

Read More

Attention RVNC Shareholders: Take Action Now with Bronstein, Gewirtz & Grossman LLC – Your Chance to Lead a Class Action Lawsuit Against Revance Therapeutics Inc. for Significant Losses

Class Action Lawsuit Filed Against Revance Therapeutics, Inc. Overview NEW YORK, NY / ACCESSWIRE / January 6, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Revance Therapeutics, Inc. (“Revance” or “the Company”) (NASDAQ:RVNC) and certain of its officers. Class Definition…

Read More

Revolutionizing the Workforce: A Comprehensive Look at the Future of Payroll Outsourcing

Dublin, Jan. 06, 2025 (GLOBE NEWSWIRE) — The “Payroll Outsourcing Market Report and Forecast 2024-2032” report has been added to ResearchAndMarkets.com’s offering. The global payroll outsourcing market size reached approximately USD 10.36 billion in 2023. Aided by the increasing demand for efficient payroll management solutions and the growing trend of business process outsourcing, the market…

Read More